Association of 3.0-T brain magnetic resonance imaging biomarkers with cognitive function in the dallas heart study

JAMA Neurology

Volumn 72, Issue 2, 2015, Pages 170-175

  Gupta, Mohit ^a   King, Kevin S ^a   Srinivasa, Rajiv ^a   Weiner, Myron F ^b   Hulsey, Keith ^a   Ayers, Colby R ^b   Whittemore, Anthony ^a   McColl, Roderick W ^a   Rossetti, Heidi C ^b   Peshock, Ronald M ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID; COGNITION; DEPTH PERCEPTION; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; MENTAL PERFORMANCE; MONTREAL COGNITIVE ASSESSMENT; MORPHOMETRICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORIENTATION; UNITED STATES; VERY ELDERLY; WHITE MATTER; ANATOMY AND HISTOLOGY; BRAIN; EPIDEMIOLOGY; MENTAL FUNCTION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

BIOLOGICAL MARKER;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN; CEREBROSPINAL FLUID; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL PROCESSES; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TEXAS; YOUNG ADULT;

EID: 84923034412     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.3418     Document Type: Article

References (39)

1. Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention Study. Ann Neurol. 2005;58(4):610-616.
2. Smith EE. Leukoaraiosis and stroke. Stroke. 2010; 41(10)(suppl):S139-S143.
3. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341(26):c3666.
4. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 2001;58(4):643-647.
5. Appel J, Potter E, Bhatia N, et al. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol. 2009;30(10):1870-1876.
6. den Heijer T, van der Lijn F, Koudstaal PJ, et al. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain. 2010;133(pt 4):1163-1172.
7. Kuller LH, Arnold AM, Longstreth WT Jr, et al. White matter grade and ventricular volume on brain MRI as markers of longevity in the Cardiovascular Health Study. Neurobiol Aging. 2007;28(9): 1307-1315.
8. Mosley TH Jr, Knopman DS, Catellier DJ, et al. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology. 2005;64(12):2056-2062.
9. Kasten M, Bruggemann N, Schmidt A, Klein C. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2010;75(5):478-479.
10. Aggarwal NT, Wilson RS, Bienias JL, et al. The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol. 2010;67(4): 475-482.
11. Luchsinger JA, Brickman AM, Reitz C, et al. Subclinical cerebrovascular disease in mild cognitive impairment. Neurology. 2009;73(6):450-456.
12. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43 (9):1683-1689.
13. Fjell AM, Walhovd KB. Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci. 2010;21(3):187-221.
14. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol Aging. 2005;26(4):491-510.
15. Stavitsky K, Du Y, Seichepine D, et al. White matter hyperintensity and cognitive functioning in the racial and ethnic minority cohort of the Framingham Heart Study. Neuroepidemiology. 2010;35(2):117-122.
16. Victor RG, Haley RW, Willett DL, et al; Dallas Heart Study Investigators. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004;93(12): 1473-1480.
17. Deo R, Khera A, McGuire DK, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol. 2004; 44(9):1812-1818.
18. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
19. Woolrich MW, Jbabdi S, Patenaude B, et al. Bayesian analysis of neuroimaging data in FSL. Neuroimage. 2009;45(1)(suppl):S173-S186.
20. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23(suppl 1):S208-S219.
21. Hulsey KM, Gupta M, King KS, Peshock RM, Whittemore AR, McColl RW. Automated quantification of white matter disease extent at 3 T: comparison with volumetric readings. J Magn Reson Imaging. 2012;36(2):305-311.
22. Jeerakathil T, Wolf PA, Beiser A, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004;35 (8):1857-1861.
23. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke. 2005;36(1): 50-55.
24. Damian AM, Jacobson SA, Hentz JG, et al. The Montreal Cognitive Assessment and the Mini-Mental State Examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. 2011;31(2):126-131.
25. Rossetti HC, Lacritz LH, Cullum CM, Weiner MF. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology. 2011;77(13):1272-1275.
26. Patel B, Markus HS. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke. 2011;6(1): 47-59.
27. Au R, Massaro JM, Wolf PA, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol. 2006;63(2):246-250.
28. Garde E, Lykke Mortensen E, Rostrup E, Paulson OB. Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry. 2005;76 (9):1289-1291.
29. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70(1):9-14.
30. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003;348(12):1170-1175.
31. Brickman AM, Schupf N, Manly JJ, et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol. 2008;65(8):1053-1061.
32. He J, Iosif AM, Lee DY, et al. Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative: pilot phase. Arch Neurol. 2010;67(10):1231-1237.
33. Carmichael O, Mungas D, Beckett L, et al. MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol Aging. 2012;33(1):83-95.
34. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52(7): 1397-1403.
35. Gorelick PB, Scuteri A, Black SE, et al; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672-2713.
36. Erkinjuntti T, Bowler JV, DeCarli CS, et al. Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord. 1999;13(suppl 3):S81-S90.
37. Saczynski JS, Sigurdsson S, Jonsdottir MK, et al. Cerebral infarcts and cognitive performance: importance of location and number of infarcts. Stroke. 2009;40(3):677-682.
38. Mungas D, Harvey D, Reed BR, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005;65(4):565-571.
39. Paul R, Lane EM, Tate DF, et al. Neuroimaging signatures and cognitive correlates of the Montreal Cognitive Assessment screen in a nonclinical elderly sample. Arch Clin Neuropsychol. 2011;26(5):454-460.